Elsevier

Brain Research

Volume 741, Issues 1–2, 25 November 1996, Pages 230-239
Brain Research

Identification of a saturable uptake system for deoxyribonucleosides at the blood-brain and blood-cerebrospinal fluid barriers

https://doi.org/10.1016/S0006-8993(96)00930-4Get rights and content

Abstract

Substances can enter the brain either directly across the blood-brain barrier or indirectly across the choroid plexuses and arachnoid membrane (blood-CSF barrier) into the CSF and then by diffusion into the brain. Earlier studies have demonstrated a saturable thymidine uptake across the blood-CSF barrier, but not across the blood-brain barrier. In this study transport of [3H]thymidine across both barriers was measured in vivo by means of a bilateral vascular brain perfusion technique in the anaesthetised guinea-pig. This method allows simultaneous and quantitative measurement of slowly penetrating solutes into both brain and CSF, under controlled conditions of arterial inflow. The results of the present study carried out over perfusion periods of up to 30 min indicated a progressive uptake of [3H]thymidine into brain and CSF, which was found to be significantly greater than the transport ofd-[14C]mannitol (a plasma space marker). Furthermore, the addition of 1 mM unlabelled thymidine in the perfusate caused saturation of [3H]thymidine uptake into both brain and CSF. In conclusion, these findings suggest that thymidine can cross both the blood-brain and blood-CSF barriers in the guinea-pig by carrier-mediated transport systems.

References (74)

  • PlagemannP.G.W. et al.

    Nucleoside and nucleobase transport in animal cells

    Biochim. Biophys. Acta

    (1988)
  • PrestonJ.E. et al.

    Permeability of the developing blood-brain barrier tot4C-mannitol using the rat in situ brain perfusion technique

    Dev. Brain Res.

    (1995)
  • RichersonG.B. et al.

    Preservation of integrative function in a perfused guinea-pig brain

    Brain. Res.

    (1990)
  • SmithQ.R. et al.

    Kinetic analysis of [36Cl]-, [22Na]- and [3H]mannitol uptake into the in vivo choroid plexus-cerebrospinal fluid brain system: ontogeny of the blood-brain and blood-CSF barriers

    Dev. Brain Res.

    (1982)
  • SpectorR.

    Thymidine accumulation by choroid plexus in vitro

    Arch. Biochem. Biophys.

    (1980)
  • SpectorR.

    Nucleoside transport in choroid plexus: mechanism and specificity

    Arch. Biochem. Biophys.

    (1982)
  • WuP.H. et al.

    Uptake by central nervous tissues as a mechanism for the regulation of extracellular adenosine concentrations

    Neurochem. Int.

    (1984)
  • WuX. et al.

    Further characterization of the sodium-dependent nucleoside transporter (N3) in choroid plexus from rabbit

    Biochim. Biophys. Acta

    (1994)
  • WuX. et al.

    Sodium-dependent nucleoside transport in choroid plexus from rabbit

    J. Biol. Chem.

    (1992)
  • YarchoanR. et al.

    Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

    Lancet

    (1986)
  • ZlokovicB.V. et al.

    Kinetics of arginine-vasopressin uptake at the blood-brain barrier

    Biochim. Biophys. Acta

    (1990)
  • Banay-SchwartzM. et al.

    Nucleoside uptake by slices of mouse brain

    J. Neurochem.

    (1980)
  • BetzA.L.

    Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries

    J. Neurochem.

    (1985)
  • BlasbergR. et al.

    Intrathecal chemotherapy: Brain tissue profiles after ventriculo-cistemal perfusion

    J. Pharmacol. Exp. Ther.

    (1975)
  • BowmanP.D. et al.

    Brain microvessel endothelial cells in tissue culture: A model for study of blood-brain barrier permeability

    Ann. Neurol.

    (1983)
  • BradburyM.W.B.

    The Concept of a Blood-Brain Barrier

    (1979)
  • BradburyM.W.B. et al.

    The blood-brain barrier interface

    Eye

    (1990)
  • BraunL.D. et al.

    Kinetics of regional blood-brain barrier glucose transport and cerebral blood flow determined with the carotid injection technique in conscious rats

    J. Neurochem.

    (1985)
  • CollinsJ.M. et al.

    Distributed model for drug delivery to CSF and brain tissue

    Am. J. Physiol.

    (1983)
  • CollinsJ.M. et al.

    Pyrimidine dideoxynucleosides: Selectivity of penetration into cerebrospinal fluid

    J. Pharmacol. Exp. Ther.

    (1988)
  • CornfordE.M. et al.

    Comparison of lipid-mediated blood-brain barrier penetrability in neonates and adults

    Am. J. Physiol.

    (1982)
  • CserrH.F. et al.

    Efflux of radiolabelled polyethylene glycols and albumin from rat brain

    Am. J. Physiol.

    (1981)
  • DavsonH. et al.

    The Physiology of the CSF and Blood-Brain Barriers

    (1996)
  • EnsmingerW.D. et al.

    The prevention of methotrexate toxicity by thymidine infusions in humans

    Cancer Res.

    (1977)
  • FinkK. et al.

    Paper chromatography of several classes of compounds: CorrelatedRf values in a variety of solvent systems

    Anal. Chem.

    (1963)
  • GeigerJ.D. et al.

    Pharmacological characterization of rapidly accumulated adenosine by dissociated brain cells from adult rat

    J. Neurochem.

    (1988)
  • GjeddeA.

    High and low- affinity transport ofd-glucose from blood to brain

    J. Neurochem.

    (1981)
  • Cited by (35)

    • BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation

      2007, Brain Research Reviews
      Citation Excerpt :

      In vitro studies suggest that BrdU is transported by the same nucleoside transporter as thymidine (Lynch et al., 1977). Thymidine enters the brain primarily through facilitative low affinity, high-capacity carrier-mediated nucleoside transport system at the BBB, and may be eliminated through the cerebrospinal fluid, like thymidine (Thomas nee Williams and Segal, 1996; Thomas et al., 1997; Spector and Berlinger, 1982). It is estimated that BrdU is available for labeling in the adult brain for approximately a 2-h period, after systemic injection.

    • The characteristics of nucleobase transport and metabolism by the perfused sheep choroid plexus

      2001, Brain Research
      Citation Excerpt :

      After the addition of 100 μM of unlabelled thymine to the perfusion medium HPLC analysis established that only thymine was present in the CSF at a concentration of 5.22±0.30 μM (n=4). The blood–brain barrier generally has a low permeability for nucleic acid precursors [4,2,35], an exception being for the nucleosides, adenosine [20] and thymidine in the guinea-pig [32,33]. It has also been shown that the transport capacity for purines at the blood–brain barrier is only sufficient to replace 2–3% of the total purines in the brain every 24 h [29].

    • Transporter-mediated permeation of drugs across the blood-brain barrier

      2000, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      Uridine distribution to brain is relatively low but saturable. However, a brain perfusion technique that is useful for slowly transported compounds at the BBB demonstrated a slow but saturable uptake of thymidine.69 Accordingly, it is suggested that both purine and pyrimidine nucleosides can be transported and purine nucleosides have higher permeability, presumably due to physiological need of a supply of purine nucleosides from blood circulation.72

    View all citing articles on Scopus
    View full text